Literature DB >> 19447008

Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes.

S M Weenink1, J Lo, C R Stephenson, P A McKinney, R Ananieva-Jordanova, B Rees Smith, J Furmaniak, J M Tremble, H J Bodansky, M R Christie.   

Abstract

B-cells influence T-cell reactivity by facilitating antigen presentation, but the role of autoantibody-secreting B-cells in regulating T-cell responses in Type 1 diabetes is poorly defined. The aims of this study were to characterise epitopes on the IA-2 autoantigen for three monoclonal antibodies from diabetic patients by amino acid substitutions of selected residues of IA-2, establish contributions of these epitopes to binding of serum antibodies in Type 1 diabetes and relate B- and T-cell responses to overlapping determinants on IA-2. The monoclonal antibodies recognised overlapping epitopes, with residues within the 831-860 region of IA-2 contributing to binding; substitution of Glu836 inhibited binding of all three antibodies. Monoclonal antibody Fab fragments and substitution of residues within the 831-836 region blocked serum antibody binding to an IA-2 643-937 construct. IL-10-secreting T-cells responding to peptides within the 831-860 region were detected by cytokine-specific ELISPOT in diabetic patients and responses to 841-860 peptide were associated with antibodies to the region of IA-2 recognised by the monoclonal antibodies. The study identifies a region of IA-2 frequently recognised by antibodies in Type 1 diabetes and demonstrates that these responses are associated with T-cells secreting IL-10 in response to a neighbouring determinant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447008     DOI: 10.1016/j.jaut.2009.04.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.

Authors:  Stef J Bloem; Bart O Roep
Journal:  Diabetologia       Date:  2017-04-24       Impact factor: 10.122

2.  Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility.

Authors:  Alistair J K Williams; Michelle Somerville; Saba Rokni; Ezio Bonifacio; Liping Yu; George Eisenbarth; Beena Akolkar; Michael Steffes; Polly J Bingley
Journal:  J Immunol Methods       Date:  2009-10-18       Impact factor: 2.303

Review 3.  T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.

Authors:  Roberto Mallone; Vedran Brezar; Christian Boitard
Journal:  Clin Dev Immunol       Date:  2011-07-19

Review 4.  Pearls in autoimmunity.

Authors:  Jozélio Freire de Carvalho; Rosa Maria Rodrigues Pereira; Yehuda Shoenfeld
Journal:  Auto Immun Highlights       Date:  2011-03-23

5.  Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes.

Authors:  Maria J Acevedo-Calado; Susan L Pietropaolo; Michael P Morran; Santiago Schnell; Andrew D Vonberg; Charles F Verge; Roberto Gianani; Dorothy J Becker; Shuai Huang; Carla J Greenbaum; Liping Yu; Howard W Davidson; Aaron W Michels; Stephen S Rich; Massimo Pietropaolo
Journal:  Diabetes       Date:  2019-06-05       Impact factor: 9.461

Review 6.  Insights From Single Cell RNA Sequencing Into the Immunology of Type 1 Diabetes- Cell Phenotypes and Antigen Specificity.

Authors:  Stephanie J Hanna; Danijela Tatovic; Terri C Thayer; Colin M Dayan
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

7.  HLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes.

Authors:  Kerry A McLaughlin; Kavita Gulati; Carolyn C Richardson; Diana Morgan; H Jonathan Bodansky; Richard G Feltbower; Michael R Christie
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

8.  The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.

Authors:  Karen T Elvers; Ivey Geoghegan; Debbie K Shoemark; Vito Lampasona; Polly J Bingley; Alistair J K Williams
Journal:  Diabetes       Date:  2012-09-10       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.